DBV Technologies (DBVT) Times Interest Earned (2020 - 2026)
DBV Technologies (DBVT) posted quarterly Times Interest Earned of -$5.69 for Q2 2026, down 26.12% year-on-year from -$7.7 in Q2 2025, and up 15.73% on a QoQ basis from -$6.75 in Q1 2026.
DBV Technologies (DBVT) Times Interest Earned (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Times Interest Earned for 7 consecutive years, with -$5.69 the latest figure, recorded in Q2 2026.
- Quarterly Times Interest Earned fell 26.12% year-over-year to -$5.69 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$19.98 (down 49.45% YoY) and the FY2025 annual result came in at -$0.4, down 12.1% from the prior year.
- Times Interest Earned climbed to -$5.69 in Q2 2026 per DBVT's latest filing, from -$6.75 in the prior quarter.
- Over the last five years, Times Interest Earned for DBVT reached as high as $271.15 in Q4 2024 and fell as low as -$171.3 in Q4 2025.
- A 5-year average of -$12.39 and a median of -$12.94 in 2023 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2024 — Times Interest Earned surged 1342.0% — and 2025, when it slumped 163.17%.
- Year by year, Times Interest Earned stood at -$57.43 in 2022, then jumped by 61.98% to -$21.83 in 2023, then jumped by 1342.0% to $271.15 in 2024, then plunged by 163.17% to -$171.3 in 2025, then soared by 96.68% to -$5.69 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$5.69, -$6.75, and -$171.3 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | -5.69 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.69 |
| Mar 31, 2026 | -6.75 |
| Dec 31, 2025 | -171.30 |
| Sep 30, 2025 | -3.80 |
| Jun 30, 2025 | -4.51 |
| Mar 31, 2025 | -3.07 |
| Dec 31, 2024 | 271.15 |
| Sep 30, 2024 | -3.34 |
| Jun 30, 2024 | -20.01 |
| Mar 31, 2024 | -14.96 |
| Dec 31, 2023 | -21.83 |
| Sep 30, 2023 | -10.20 |
| Jun 30, 2023 | -10.93 |
| Mar 31, 2023 | -42.67 |
| Dec 31, 2022 | -57.43 |
| Sep 30, 2022 | -24.55 |
| Jun 30, 2022 | -64.39 |
| Mar 31, 2022 | -28.77 |
| Dec 31, 2021 | -396.38 |
| Sep 30, 2021 | -31.73 |